Afuco™ Anti-Human CXC-ELR ADCC Therapeutic Antibody, ADCC Enhanced
Anti-CXC-ELR ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antibodies specifically bind seven human ELR+ CXC chemokines are useful for treating various inflammatory/autoimmune diseases, such as inflammatory bowel disease (IBD), plaque psoriasis, and palmoplantar pustulosis; and cancer, such as renal cancer or ovarian cancer.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-187CL |
| Pricing | Inquiry |
| Host | Human |
| Target | CXC-ELR |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store at -20°C for long-term storage. Store at 4°C for up to one month. Avoid freeze/thaw cycles. |